Searched for: in-biosketch:true
person:mendod05
Cultivating Future Radiology Educators: Development and Implementation of a Clinician-Educator Track for Residents
Mendoza, Dexter; Peterson, Ryan; Ho, Christopher; Harri, Peter; Baumgarten, Deborah; Mullins, Mark E
Effective and dedicated educators are critical to the preservation and advancement of the practice of radiology. The need for innovative and adaptable educators is increasingly being recognized, with several institutions granting academic promotions through clinician-educator tracks. The implementation of resident "clinician-educator tracks" or "teaching tracks" should better prepare residents aspiring to become academic radiologists focused on teaching. In this work, we describe our experience in the development and implementation of a clinician-educator track for diagnostic radiology residents at our institution.
PMID: 29731418
ISSN: 1878-4046
CID: 5773722
Use of Conventional and Advanced MRI Techniques in Accidental Pediatric Traumatic Brain Injury [Review]
Mendoza, Dexter; Kadom, Nadja; Palasis, Susan; Milla, Sarah; Allen, Jason W.
ISI:000417692800005
ISSN: 1309-6680
CID: 5773862
Eptifibatide and Cirrhosis: Rethinking GPIIb-IIIa Inhibitors for Acute Coronary Syndrome in the Setting of Liver Dysfunction [Case Report]
Weinreich, Michael; Mendoza, Dexter; Pettei, Thomas; Grayver, Evelina
Glycoprotein IIb/IIIa (GPIIb/IIIa) inhibitors, such as eptifibatide, are routinely used in the setting of acute coronary syndrome (ACS) prior to or during percutaneous coronary intervention (PCI). While numerous studies have demonstrated improved clinical outcomes with eptifibatide use, adverse effects including thrombocytopenia have also been noted. For this reason, patients with baseline thrombocytopenia or liver disease should be cautiously evaluated prior to drug administration. Here we report a case of acute profound and prolonged eptifibatide-induced thrombocytopenia in a patient with cirrhotic liver dysfunction. We propose and discuss the need for a risk stratification tool to be established for identifying which patients with ACS in the setting of chronic liver disease receive GPIIb/IIIa inhibitors.
PMCID:5358269
PMID: 28352453
ISSN: 1923-2829
CID: 5773712